These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15990182)

  • 21. Pharmacological characterization of STKR, an insect G protein-coupled receptor for tachykinin-like peptides.
    Torfs H; Oonk HB; Broeck JV; Poels J; Van Poyer W; De Loof A; Guerrero F; Meloen RH; Akerman K; Nachman RJ
    Arch Insect Biochem Physiol; 2001 Sep; 48(1):39-49. PubMed ID: 11519074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional characterization of opioid receptor ligands by aequorin luminescence-based calcium assay.
    Fichna J; Gach K; Piestrzeniewicz M; Burgeon E; Poels J; Broeck JV; Janecka A
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1150-4. PubMed ID: 16497786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and molecular characterization of tachykinins and tachykinin receptors in the mouse uterus.
    Patak E; Pinto FM; Story ME; Pintado CO; Fleming A; Page NM; Pennefather JN; Candenas ML
    Biol Reprod; 2005 May; 72(5):1125-33. PubMed ID: 15647454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of intracellular calcium in cell populations loaded with aequorin: neurokinin-1 responses in U373MG cells.
    Hedley L; Phagoo SB; James IF
    Anal Biochem; 1996 May; 236(2):270-4. PubMed ID: 8660504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mu-opioid receptor ligands lack receptor subtype selectivity in the aequorin luminescence-based calcium assay.
    Fichna J; Staniszewska R; Poels J; Vanden Broeck J; Janecka A
    Chem Biol Drug Des; 2007 Sep; 70(3):247-53. PubMed ID: 17718719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
    Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening.
    Gilchrist MA; Cacace A; Harden DG
    J Biomol Screen; 2008 Jul; 13(6):486-93. PubMed ID: 18566482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors.
    Ungrin MD; Singh LM; Stocco R; Sas DE; Abramovitz M
    Anal Biochem; 1999 Jul; 272(1):34-42. PubMed ID: 10405290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of aequorin for G protein-coupled receptor hit identification and compound profiling.
    Brough SJ; Shah P
    Methods Mol Biol; 2009; 552():181-98. PubMed ID: 19513650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subtype- and species-selectivity of a tachykinin receptor antagonist, FK888, for cloned rat and human tachykinin receptors.
    Aramori I; Morikawa N; Zenkoh J; O'Donnell N; Iwami M; Kojo H; Notsu Y; Okuhara M; Ono S; Nakanishi S
    Eur J Pharmacol; 1994 Oct; 269(2):277-81. PubMed ID: 7531648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extending the understanding of sensory neuropeptides.
    De Swert KO; Joos GF
    Eur J Pharmacol; 2006 Mar; 533(1-3):171-81. PubMed ID: 16464447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence and pharmacological characterization of four human tachykinin NK2 receptor variants.
    Ahlstedt I; Engberg S; Smith J; Perrey C; Moody A; Morten J; Lagerström-Fermér M; Drmota T; von Mentzer B; Påhlman I; Lindström E
    Biochem Pharmacol; 2008 Aug; 76(4):476-81. PubMed ID: 18601911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexpression of preprotachykinin A and B transcripts in the bovine corpus luteum and evidence for functional neurokinin receptor activity in luteal endothelial cells and ovarian macrophages.
    Brylla E; Aust G; Geyer M; Uckermann O; Löffler S; Spanel-Borowski K
    Regul Pept; 2005 Feb; 125(1-3):125-33. PubMed ID: 15582723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.
    Walstab J; Combrink S; Brüss M; Göthert M; Niesler B; Bönisch H
    Anal Biochem; 2007 Sep; 368(2):185-92. PubMed ID: 17617370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NK1, NK2, NK3 and CGRP1 receptors identified in rat oral soft tissues, and in bone and dental hard tissue cells.
    Fristad I; Vandevska-Radunovic V; Fjeld K; Wimalawansa SJ; Hals Kvinnsland I
    Cell Tissue Res; 2003 Mar; 311(3):383-91. PubMed ID: 12658446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of new semisynthetic aequorins with long half-decay time of luminescence to G-protein-coupled receptor assay.
    Inouye S; Iimori R; Sahara Y; Hisada S; Hosoya T
    Anal Biochem; 2010 Dec; 407(2):247-52. PubMed ID: 20800051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptor.
    Perrine SA; Beard DJ; Young JK; Simmons MA
    Eur J Pharmacol; 2008 Sep; 592(1-3):1-6. PubMed ID: 18634782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high-throughput glow-type aequorin assay for measuring receptor-mediated changes in intracellular calcium levels.
    George SE; Schaeffer MT; Cully D; Beer MS; McAllister G
    Anal Biochem; 2000 Nov; 286(2):231-7. PubMed ID: 11067745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
    Garland AM; Grady EF; Lovett M; Vigna SR; Frucht MM; Krause JE; Bunnett NW
    Mol Pharmacol; 1996 Mar; 49(3):438-46. PubMed ID: 8643083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
    Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
    Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.